✦ LIBER ✦

Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease

✍ Scribed by Soon-Won Park; Sun-Hee Kim; Kyu-Hyun Park; Sang-Doo Kim; Joo-Young Kim; Sun-Yong Baek; Byung-Seon Chung; Chi-Dug Kang

Book ID: 116766670
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 268 KB
Volume: 363
Category: Article
ISSN: 0304-3940
DOI: 10.1016/j.neulet.2004.03.072

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunological changes in the MPTP-induce

Immunological changes in the MPTP-induced Parkinson's disease mouse model

✍ Katarzyna Bieganowska; Anna Członkowska; Andrzej Bidziński; Hanna Mierzewska; Ja 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 386 KB

Tauroursodeoxycholic Acid Prevents MPTP-

Tauroursodeoxycholic Acid Prevents MPTP-Induced Dopaminergic Cell Death in a Mouse Model of Parkinson’s Disease

✍ Castro-Caldas, M.; Carvalho, A. Neves; Rodrigues, E.; Henderson, C. J.; Wolf, C. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 709 KB

Behavioral and biochemical effects of ni

Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson's disease

✍ Henry Sershen; Audrey Hashim; Abel Lajtha 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 446 KB

Immunological changes in the MPTP induce

Immunological changes in the MPTP induced parkinson disease mouse model

✍ A. Cztonkowska; K. Piotrowska; H. Mierzewska; A. Bidziński 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Neuroprotective effects of echinacoside

Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease

✍ Xingchao Geng; Xuefei Tian; Pengfei Tu; Xiaoping Pu 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 626 KB

Neuroprotective effects of (±)-kavain in

Neuroprotective effects of (±)-kavain in the MPTP mouse model of Parkinson's disease

✍ Nicole Schmidt; Boris Ferger 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

This is the first study to investigate the potential protective effects of the lipophilic kavapyrone (+/-)-kavain in the experimental MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease (PD). Male C57BL/6 mice were treated with (+/-)-kavain (50, 100, or 200 mg/kg i.p.) o